Patents by Inventor Charlene L. Burns

Charlene L. Burns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic nucleosides
    Patent number: 5637574
    Abstract: Compounds or formula (I), wherein R.sup.1 represents an n-propoxy, cyclobutoxy, cyclopropylamino, piperidino or pyrrolidino group; or a physiologically functional derivative thereof. The invention further includes methods for the preparation of compounds of formula (I), compositions containing them and the use of these compounds as antiviral agents.
    Type: Grant
    Filed: October 5, 1994
    Date of Patent: June 10, 1997
    Assignee: Glaxo Wellcome Inc.
    Inventors: Charlene L. Burns, George W. Koszalka, Thomas A. Krenitsky, Susan M. Daluge
  • Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine
    Patent number: 5574149
    Abstract: A method for treating HIV infections comprising administering a composition whose active ingredient is 2',3'-dideoxy-3'-fluoro-5'-chlorouridine.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: November 12, 1996
    Assignee: Glaxo Wellcome Inc.
    Inventors: Joel Van Tuttle, Susan M. Daluge, Charlene L. Burns, George W. Koszalka, Thomas A. Krenitsky
  • Therapeutic nucleosides
    Patent number: 5185437
    Abstract: This invention relates to certain 6-substituted 2',3'-dideoxypurine nucleosides and pharmaceutically acceptable derivatives thereof and their use in the treatment of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections. Also provided are pharmaceutical formulations and processes for the production of the compounds of the invention.
    Type: Grant
    Filed: August 31, 1991
    Date of Patent: February 9, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: George W. Koszalka, Charlene L. Burns, Thomas A. Krenitsky, Janet L. Rideout
  • 2-amino-6-(cyclopropylamino)purine-9-.beta.-D-2',3'-dideo xyribofuranoside and its pharmaceutically acceptable salts
    Patent number: 5068320
    Abstract: This invention relates to certain 6-substituted 2',3'-dideoxypurine nucleosides and derivatives thereof. The compounds are useful as antivirals.
    Type: Grant
    Filed: October 6, 1989
    Date of Patent: November 26, 1991
    Assignee: Burroughs Wellcome Co.
    Inventors: George W. Koszalka, Charlene L. Burns, Thomas A. Krenitsky, Janet L. Rideout